Global Gene Editing Market Size, Status and Forecast 2022-2028

Published: March 1, 2022 |

QYResearch | 92 Pages | Delivery time: 2-3 business days

Price

Description
Table of Contents
List of Tables

Add to Compare

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.

Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

According to our latest research, the global Gene Editing market size will reach USD 5441.3 million in 2028, growing at a CAGR of 7.9% over the analysis period.

Global Gene Editing Scope and Market Size

This report focuses on the global Gene Editing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Editing development in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, etc.

Segment by Type

Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system

Segment by Application

Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

By Company

Thermo Fisher Scientific
Merck
Horizon Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech

1 Report Overview

1.1 Study Scope
1.2 Market Analysis by Type
- 1.2.1 Global Gene Editing Market Size Growth Rate by Type (2022-2028)
- 1.2.2 Zinc finger nucleases (ZFNs)
- 1.2.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
- 1.2.4 CRISPR-Cas system
1.3 Market by Application
- 1.3.1 Global Gene Editing Market Share by Application (2022-2028)
- 1.3.2 Biotechnology & Pharmaceutical Companies
- 1.3.3 Academic & Government Research Institutes
- 1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Gene Editing Market Size
2.2 Gene Editing Market Size by Regions
- 2.2.1 Gene Editing Growth Rate by Regions (2022-2028)
- 2.2.2 Gene Editing Market Share by Regions (2022-2028)
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Use Cases

3 Key Players

3.1 Gene Editing Revenue by Players (2022 & 2028)
3.2 Gene Editing Key Players Headquarters and Area Served
3.3 Key Players Gene Editing Product/Solution/Service
3.4 Date of Enter into Gene Editing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application

4.1 Global Gene Editing Market Size by Type (2022-2028)
4.2 Global Gene Editing Market Size by Application (2022-2028)

5 North America

5.1 North America Gene Editing Market Forecast (2022-2028)
5.2 Gene Editing Key Players in North America
5.3 North America Gene Editing Market Size by Type
5.4 North America Gene Editing Market Size by Application

6 Europe

6.1 Europe Gene Editing Market Forecast (2022-2028)
6.2 Gene Editing Key Players in Europe
6.3 Europe Gene Editing Market Size by Type
6.4 Europe Gene Editing Market Size by Application

7 Asia-Pacific

7.1 Asia-Pacific Gene Editing Market Forecast (2022-2028)
7.2 Gene Editing Key Players in Asia-Pacific
7.3 Asia-Pacific Gene Editing Market Size by Type
7.4 Asia-Pacific Gene Editing Market Size by Application

8 Rest of World

8.1 Latin America
- 8.1.1 Latin America Gene Editing Market Analysis
- 8.1.2 Key Players in Latin America
8.2 Middle East & Africa
- 8.2.1 Middle East & Africa Gene Editing Market Analysis
- 8.2.2 Key Players in Middle East & Africa

9 International Player Profiles

9.1 Thermo Fisher Scientific
- 9.1.1 Thermo Fisher Scientific Company Details
- 9.1.2 Thermo Fisher Scientific Description and Business Overview
- 9.1.3 Thermo Fisher Scientific Gene Editing Introduction
- 9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2022 & 2028)
- 9.1.5 Thermo Fisher Scientific Recent Development
9.2 Merck
- 9.2.1 Merck Company Details
- 9.2.2 Merck Description and Business Overview
- 9.2.3 Merck Gene Editing Introduction
- 9.2.4 Merck Revenue in Gene Editing Business (2022 & 2028)
- 9.2.5 Merck Recent Development
9.3 Horizon Discovery
- 9.3.1 Horizon Discovery Company Details
- 9.3.2 Horizon Discovery Description and Business Overview
- 9.3.3 Horizon Discovery Gene Editing Introduction
- 9.3.4 Horizon Discovery Revenue in Gene Editing Business (2022 & 2028)
- 9.3.5 Horizon Discovery Recent Development
9.4 Sangamo BioSciences
- 9.4.1 Sangamo BioSciences Company Details
- 9.4.2 Sangamo BioSciences Description and Business Overview
- 9.4.3 Sangamo BioSciences Gene Editing Introduction
- 9.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2022 & 2028)
- 9.4.5 Sangamo BioSciences Recent Development
9.5 Integrated DNA Technologies
- 9.5.1 Integrated DNA Technologies Company Details
- 9.5.2 Integrated DNA Technologies Description and Business Overview
- 9.5.3 Integrated DNA Technologies Gene Editing Introduction
- 9.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2022 & 2028)
- 9.5.5 Integrated DNA Technologies Recent Development
9.6 Lonza
- 9.6.1 Lonza Company Details
- 9.6.2 Lonza Description and Business Overview
- 9.6.3 Lonza Gene Editing Introduction
- 9.6.4 Lonza Revenue in Gene Editing Business (2022 & 2028)
- 9.6.5 Lonza Recent Development
9.7 New England Biolabs
- 9.7.1 New England Biolabs Company Details
- 9.7.2 New England Biolabs Description and Business Overview
- 9.7.3 New England Biolabs Gene Editing Introduction
- 9.7.4 New England Biolabs Revenue in Gene Editing Business (2022 & 2028)
- 9.7.5 New England Biolabs Recent Development
9.8 OriGene Technologies
- 9.8.1 OriGene Technologies Company Details
- 9.8.2 OriGene Technologies Description and Business Overview
- 9.8.3 OriGene Technologies Gene Editing Introduction
- 9.8.4 OriGene Technologies Revenue in Gene Editing Business (2022 & 2028)
- 9.8.5 OriGene Technologies Recent Development
9.9 Transposagen Biopharmaceuticals
- 9.9.1 Transposagen Biopharmaceuticals Company Details
- 9.9.2 Transposagen Biopharmaceuticals Description and Business Overview
- 9.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
- 9.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2022 & 2028)
- 9.9.5 Transposagen Biopharmaceuticals Recent Development
9.10 Editas Medicine
- 9.10.1 Editas Medicine Company Details
- 9.10.2 Editas Medicine Description and Business Overview
- 9.10.3 Editas Medicine Gene Editing Introduction
- 9.10.4 Editas Medicine Revenue in Gene Editing Business (2022 & 2028)
- 9.10.5 Editas Medicine Recent Development
9.11 CRISPR Therapeutics
- 9.11.1 CRISPR Therapeutics Company Details
- 9.11.2 CRISPR Therapeutics Description and Business Overview
- 9.11.3 CRISPR Therapeutics Gene Editing Introduction
- 9.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2022 & 2028)
- 9.11.5 CRISPR Therapeutics Recent Development
9.12 RGen Solutions
- 9.12.1 RGen Solutions Company Details
- 9.12.2 RGen Solutions Description and Business Overview
- 9.12.3 RGen Solutions Gene Editing Introduction
- 9.12.4 RGen Solutions Revenue in Gene Editing Business (2022 & 2028)
- 9.12.5 RGen Solutions Recent Development
9.13 Sigma-Aldrich
- 9.13.1 Sigma-Aldrich Company Details
- 9.13.2 Sigma-Aldrich Description and Business Overview
- 9.13.3 Sigma-Aldrich Gene Editing Introduction
- 9.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2022 & 2028)
- 9.13.5 Sigma-Aldrich Recent Development
9.14 GeneCopoeia
- 9.14.1 GeneCopoeia Company Details
- 9.14.2 GeneCopoeia Description and Business Overview
- 9.14.3 GeneCopoeia Gene Editing Introduction
- 9.14.4 GeneCopoeia Revenue in Gene Editing Business (2022 & 2028)
- 9.14.5 GeneCopoeia Recent Development
9.15 Genscript Biotech
- 9.15.1 Genscript Biotech Company Details
- 9.15.2 Genscript Biotech Description and Business Overview
- 9.15.3 Genscript Biotech Gene Editing Introduction
- 9.15.4 Genscript Biotech Revenue in Gene Editing Business (2022 & 2028)
- 9.15.5 Genscript Biotech Recent Development

10 Market Dynamics

10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report

12 Appendix

12.1 Research Methodology
- 12.1.1 Methodology/Research Approach
- 12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

LIST OF TABLES

List of Tables

Table 1. Global Gene Editing Market Size Growth Rate by Type (2022-2028) (US$ Million)
Table 2. Key Players of Zinc finger nucleases (ZFNs)
Table 3. Key Players of Transcription Activator-Like Effector-based Nucleases (TALENs)
Table 4. Key Players of CRISPR-Cas system
Table 5. Global Gene Editing Market Size Growth by Application (2022-2028) (US$ Million)
Table 6. Global Gene Editing Market Size by Regions (2022-2028) (US$ Million)
Table 7. Global Gene Editing Market Share by Regions (2022-2028)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global Gene Editing Revenue by Players (2022 & 2028) (US$ Million)
Table 11. Global Gene Editing Market Share by Players (2022 &2028)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players Gene Editing Product/Solution/Service
Table 14. Date of Enter into Gene Editing Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Gene Editing Market Size by Type (2022-2028) (US$ Million)
Table 17. Global Gene Editing Market Size Share by Type (2022-2028)
Table 18. Global Gene Editing Market Size by Application (2022-2028) (US$ Million)
Table 19. Global Gene Editing Market Size Share by Application (2022-2028)
Table 20. North America Key Players Gene Editing Revenue (2022 & 2028) & (US$ Million)
Table 21. North America Key Players Gene Editing Market Share (2022 & 2028)
Table 22. North America Gene Editing Market Size by Type (2022-2028) (US$ Million)
Table 23. North America Gene Editing Market Share by Type (2022-2028)
Table 24. North America Gene Editing Market Size by Application (2022-2028) (US$ Million)
Table 25. North America Gene Editing Market Share by Application (2022-2028)
Table 26. Europe Key Players Gene Editing Revenue (2022 & 2028) & (US$ Million)
Table 27. Europe Key Players Gene Editing Market Share (2022 & 2028)
Table 28. Europe Gene Editing Market Size by Type (2022-2028) (US$ Million)
Table 29. Europe Gene Editing Market Share by Type (2022-2028)
Table 30. Europe Gene Editing Market Size by Application (2022-2028) (US$ Million)
Table 31. Europe Gene Editing Market Share by Application (2022-2028)
Table 32. Asia-Pacific Key Players Gene Editing Revenue (2022 & 2028) & (US$ Million)
Table 33. Asia-Pacific Key Players Gene Editing Market Share (2022 & 2028)
Table 34. Asia-Pacific Gene Editing Market Size by Type (2022-2028) (US$ Million)
Table 35. Asia-Pacific Gene Editing Market Share by Type (2022-2028)
Table 36. Asia-Pacific Gene Editing Market Size by Application (2022-2028) (US$ Million)
Table 37. Asia-Pacific Gene Editing Market Share by Application (2022-2028)
Table 38. Key Players in Latin America
Table 39. Key Players in Middle East & Africa
Table 40. Thermo Fisher Scientific Company Details
Table 41. Thermo Fisher Scientific Description and Business Overview
Table 42. Thermo Fisher Scientific Gene Editing Product
Table 43. Thermo Fisher Scientific Revenue in Gene Editing Business 2022 & 2028
Table 44. Thermo Fisher Scientific Recent Development
Table 45. Merck Company Details
Table 46. Merck Description and Business Overview
Table 47. Merck Gene Editing Product
Table 48. Merck Revenue in Gene Editing Business 2022 & 2028
Table 49. Merck Recent Development
Table 50. Horizon Discovery Company Details
Table 51. Horizon Discovery Description and Business Overview
Table 52. Horizon Discovery Gene Editing Product
Table 53. Horizon Discovery Revenue in Gene Editing Business 2022 & 2028
Table 54. Horizon Discovery Recent Development
Table 55. Sangamo BioSciences Company Details
Table 56. Sangamo BioSciences Description and Business Overview
Table 57. Sangamo BioSciences Gene Editing Product
Table 58. Sangamo BioSciences Revenue in Gene Editing Business 2022 & 2028
Table 59. Sangamo BioSciences Recent Development
Table 60. Integrated DNA Technologies Company Details
Table 61. Integrated DNA Technologies Description and Business Overview
Table 62. Integrated DNA Technologies Gene Editing Product
Table 63. Integrated DNA Technologies Revenue in Gene Editing Business 2022 & 2028
Table 64. Integrated DNA Technologies Recent Development
Table 65. Lonza Company Details
Table 66. Lonza Description and Business Overview
Table 67. Lonza Gene Editing Product
Table 68. Lonza Revenue in Gene Editing Business 2022 & 2028
Table 69. Lonza Recent Development
Table 70. New England Biolabs Company Details
Table 71. New England Biolabs Description and Business Overview
Table 72. New England Biolabs Gene Editing Product
Table 73. New England Biolabs Revenue in Gene Editing Business 2022 & 2028
Table 74. New England Biolabs Recent Development
Table 75. OriGene Technologies Company Details
Table 76. OriGene Technologies Description and Business Overview
Table 77. OriGene Technologies Gene Editing Product
Table 78. OriGene Technologies Revenue in Gene Editing Business 2022 & 2028
Table 79. OriGene Technologies Recent Development
Table 80. Transposagen Biopharmaceuticals Company Details
Table 81. Transposagen Biopharmaceuticals Description and Business Overview
Table 82. Transposagen Biopharmaceuticals Gene Editing Product
Table 83. Transposagen Biopharmaceuticals Revenue in Gene Editing Business 2022 & 2028
Table 84. Transposagen Biopharmaceuticals Recent Development
Table 85. Editas Medicine Company Details
Table 86. Editas Medicine Description and Business Overview
Table 87. Editas Medicine Gene Editing Product
Table 88. Editas Medicine Revenue in Gene Editing Business 2022 & 2028
Table 89. Editas Medicine Recent Development
Table 90. CRISPR Therapeutics Company Details
Table 91. CRISPR Therapeutics Description and Business Overview
Table 92. CRISPR Therapeutics Gene Editing Product
Table 93. CRISPR Therapeutics Revenue in Gene Editing Business 2022 & 2028
Table 94. CRISPR Therapeutics Recent Development
Table 95. RGen Solutions Company Details
Table 96. RGen Solutions Description and Business Overview
Table 97. RGen Solutions Gene Editing Product
Table 98. RGen Solutions Revenue in Gene Editing Business 2022 & 2028
Table 99. RGen Solutions Recent Development
Table 100. Sigma-Aldrich Company Details
Table 101. Sigma-Aldrich Description and Business Overview
Table 102. Sigma-Aldrich Gene Editing Product
Table 103. Sigma-Aldrich Revenue in Gene Editing Business 2022 & 2028
Table 104. Sigma-Aldrich Recent Development
Table 105. GeneCopoeia Company Details
Table 106. GeneCopoeia Description and Business Overview
Table 107. GeneCopoeia Gene Editing Product
Table 108. GeneCopoeia Revenue in Gene Editing Business 2022 & 2028
Table 109. GeneCopoeia Recent Development
Table 110. Genscript Biotech Company Details
Table 111. Genscript Biotech Description and Business Overview
Table 112. Genscript Biotech Gene Editing Product
Table 113. Genscript Biotech Revenue in Gene Editing Business 2022 & 2028
Table 114. Genscript Biotech Recent Development
Table 115. Gene Editing Market Trends
Table 116. Gene Editing Market Drivers
Table 117. Gene Editing Market Challenges
Table 118. Gene Editing Market Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Editing Market Share by Type in 2022 & 2028
Figure 2. Zinc finger nucleases (ZFNs) Features
Figure 3. Transcription Activator-Like Effector-based Nucleases (TALENs) Features
Figure 4. CRISPR-Cas system Features
Figure 5. Global Gene Editing Market Share by Application in 2022 & 2028
Figure 6. Biotechnology & Pharmaceutical Companies Case Studies
Figure 7. Academic & Government Research Institutes Case Studies
Figure 8. Contract Research Organizations Case Studies
Figure 9. Gene Editing Report Years Considered
Figure 10. Global Gene Editing Market Size and Growth Rate (2022-2028) (US$ Million)
Figure 11. Global Gene Editing Market Share by Regions (2022-2028)
Figure 12. Global Gene Editing Market Share by Players in 2021
Figure 13. Global Gene Editing Market Size Market Share by Type (2022-2028)
Figure 14. Global Gene Editing Market Size Market Share by Application (2022-2028)
Figure 15. Global Gene Editing Revenue Market Share by Application in 2021
Figure 16. North America Gene Editing Market Size 2022-2028 (US$ Million)
Figure 17. Europe Gene Editing Market Size 2022-2028 (US$ Million)
Figure 18. Asia-Pacific Gene Editing Market Size 2022-2028 (US$ Million)
Figure 19. Gene Editing Market Size in Latin America (2022-2028) (US$ Million)
Figure 20. Gene Editing Market Size in Middle East & Africa (2022-2028) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed